A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial-Reference-Cited by-同舟云学术

A cardiovascular polypill for secondary stroke prevention in a tertiary centre in Ghana (SMAART): a phase 2 randomised clinical trial

Published:2023-10 Issue:10 Volume:11 Page:e1619-e1628
ISSN:2214-109X
Container-title:The Lancet Global Health
language:en
Short-container-title:The Lancet Global Health

Author:

Sarfo Fred Stephen,Voeks Jenifer,Adamu Sheila,Agyei Benedict Apaw,Agbenorku Manolo,Adu-Darko Nyantakyi,Oteng Mercy Adomah,Obese Vida,Gyamfi Rexford Adu,Mensah Nathaniel Adusei,Tagge Raelle,Ampofo Michael,Kontoh Samuel Amoabeng,Nguah Samuel Blay,Ovbiagele Bruce

Funder

National Institute of Neurological Disorders and Stroke

National Institutes of Health

National Heart, Lung, and Blood Institute

Publisher

Elsevier BV

Subject

General Medicine

Reference29 articles.

1. Guideline for the prevention of stroke in patients with stroke and transient ischaemic attack;Kleindorfer;Stroke,2021

2. European Stroke Organisation (ESO) guideline on pharmacological interventions for long-term secondary prevention after ischaemic stroke or transient ischaemic attack;Dawson;Eur Stroke J,2022

3. Optimal combination secondary prevention drug treatment and stroke outcomes;Park;Neurology,2015

4. Baseline prescription and one-year persistence of secondary prevention drugs after an index stroke in central Ghana;Sarfo;eNeurologicalSci,2017

5. Medication adherence early after stroke: using the Perceptions and Practicalities Framework to explore stroke survivors', informal carers' and nurses' experiences of barriers and solutions;Gibson;J Res Nurs,2021

Cited by 4 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of a Cardiovascular Polypill on Poststroke Cognition Among Ghanaians: Secondary Analysis of a Randomized Clinical Trial;Journal of the American Heart Association;2024-08-06

2. New pharmacological agents and novel cardiovascular pharmacotherapy strategies in 2023;European Heart Journal - Cardiovascular Pharmacotherapy;2024-02-20

3. The p-value framework for building and sustaining a stroke research enterprise in a high-risk and low-income region;Journal of the Neurological Sciences;2023-12

4. The place of polypill in secondary prevention of stroke;The Lancet Global Health;2023-10